{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Elecoglipron", "query": { "intervention": "Elecoglipron" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-01T11:53:58.742Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07761117", "title": "A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Heart Failure With Preserved Ejection Fraction (HFpEF)", "Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)" ], "interventions": [ { "name": "Elecoglipron", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6950, "start_date": "2026-08-28", "completion_date": "2029-09-03", "has_results": false, "last_update_posted_date": "2026-08-12", "last_synced_at": "2026-09-01T11:53:58.742Z", "location_count": 69, "location_summary": "Fairhope, Alabama • Beverly Hills, California • Huntington Beach, California + 62 more", "locations": [ { "city": "Fairhope", "state": "Alabama" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Huntington Park", "state": "California" }, { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07761117" }, { "nct_id": "NCT07723833", "title": "A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "Elecoglipron Reference Formulation Dose A", "type": "DRUG" }, { "name": "Elecoglipron Test formulation 1 Dose A", "type": "DRUG" }, { "name": "Elecoglipron Reference Formulation Dose B", "type": "DRUG" }, { "name": "Elecoglipron Test formulation 1 Dose B", "type": "DRUG" }, { "name": "Elecoglipron Test formulation 2 Dose A", "type": "DRUG" }, { "name": "Elecoglipron Test formulation 2 Dose B", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 152, "start_date": "2026-07-27", "completion_date": "2026-11-18", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-09-01T11:53:58.742Z", "location_count": 2, "location_summary": "Glendale, California • Brooklyn, Maryland", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Brooklyn", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07723833" }, { "nct_id": "NCT07667803", "title": "A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Weight Management" ], "interventions": [ { "name": "Elecoglipron", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4500, "start_date": "2026-06-29", "completion_date": "2029-07-30", "has_results": false, "last_update_posted_date": "2026-07-10", "last_synced_at": "2026-09-01T11:53:58.742Z", "location_count": 56, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Chandler, Arizona + 53 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07667803" }, { "nct_id": "NCT07662044", "title": "A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Elecoglipron", "type": "DRUG" }, { "name": "Dapagliflozin", "type": "DRUG" }, { "name": "Elecoglipron-matched placebo", "type": "DRUG" }, { "name": "Dapagliflozin-matched placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 800, "start_date": "2026-07-06", "completion_date": "2028-07-14", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-09-01T11:53:58.742Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Daphne, Alabama • Lomita, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Daphne", "state": "Alabama" }, { "city": "Lomita", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07662044" }, { "nct_id": "NCT07662109", "title": "A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Elecoglipron", "type": "DRUG" }, { "name": "Dapagliflozin", "type": "DRUG" }, { "name": "Elecoglipron-matched placebo", "type": "DRUG" }, { "name": "Dapagliflozin-matched placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2000, "start_date": "2026-07-06", "completion_date": "2028-07-05", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-09-01T11:53:58.742Z", "location_count": 40, "location_summary": "Huntsville, Alabama • Mobile, Alabama • Sheffield, Alabama + 36 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Sheffield", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07662109" }, { "nct_id": "NCT07753993", "title": "A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Kidney Disease" ], "interventions": [ { "name": "Elecoglipron", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7000, "start_date": "2026-08-28", "completion_date": "2030-10-04", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-09-01T11:53:58.742Z", "location_count": 33, "location_summary": "Sheffield, Alabama • Surprise, Arizona • Chula Vista, California + 29 more", "locations": [ { "city": "Sheffield", "state": "Alabama" }, { "city": "Surprise", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Waterbury", "state": "Connecticut" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07753993" }, { "nct_id": "NCT07664553", "title": "A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Elecoglipron", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 600, "start_date": "2026-07-08", "completion_date": "2028-05-23", "has_results": false, "last_update_posted_date": "2026-08-04", "last_synced_at": "2026-09-01T11:53:58.742Z", "location_count": 17, "location_summary": "Little Rock, Arkansas • Sacramento, California • Aurora, Colorado + 14 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Sacramento", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "DeLand", "state": "Florida" }, { "city": "Doral", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07664553" }, { "nct_id": "NCT07662213", "title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Elecoglipron", "type": "DRUG" }, { "name": "Semaglutide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1200, "start_date": "2026-07-06", "completion_date": "2028-05-23", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-09-01T11:53:58.742Z", "location_count": 63, "location_summary": "Birmingham, Alabama • Mesa, Arizona • Phoenix, Arizona + 56 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Covina", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "nct_id": "NCT07534592", "title": "A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "Elecoglipron", "type": "DRUG" }, { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Rosuvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 48, "start_date": "2026-04-16", "completion_date": "2026-10-01", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-09-01T11:53:58.742Z", "location_count": 2, "location_summary": "Glendale, California • Brooklyn, Maryland", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Brooklyn", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07534592" }, { "nct_id": "NCT07662135", "title": "A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus", "Type 2 Diabetes With Chronic Kidney Disease" ], "interventions": [ { "name": "Elecoglipron", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 900, "start_date": "2026-07-06", "completion_date": "2028-07-13", "has_results": false, "last_update_posted_date": "2026-08-04", "last_synced_at": "2026-09-01T11:53:58.742Z", "location_count": 33, "location_summary": "Peoria, Arizona • Surprise, Arizona • Concord, California + 29 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Surprise", "state": "Arizona" }, { "city": "Concord", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Victorville", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07662135" } ] }